近5年高被引文献
Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee
article
Full Text
OpenAlex
1037
FWCI122.81712126
The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity
article
Full Text
OpenAlex
440
FWCI51.60680961
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
article
Full Text
OpenAlex
418
FWCI64.86836977
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
article
Full Text
OpenAlex
398
FWCI68.13775126
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
article
Full Text
OpenAlex
370
FWCI83.74072078
Bimekizumab versus Secukinumab in Plaque Psoriasis
article
Full Text
OpenAlex
348
FWCI27.35370517
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
article
Full Text
OpenAlex
338
FWCI86.13598705
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
review
Full Text
OpenAlex
305
FWCI43.06142054
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
article
Full Text
OpenAlex
290
FWCI49.42702184